Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation
- 129 Downloads
Esophageal cancer-related gene 4 (ECRG4) has been proposed as a putative tumor suppressor gene in several tumors. However, the role and regulation of ECRG4 in the pathogenesis of human renal cancer remain largely unknown. Our current study revealed that expression of ECRG4 is downregulated in renal cell lines and renal cancer tissues. ECRG4 expression was significantly associated with histological grade of tumors (p < 0.001), primary tumor stage (p = 0.017), and distant metastasis (p = 0.017). Low expression of ECRG4 was an independent prognostic indicator for survival of renal cancer patients. Silencing of ECRG4 expression in renal cell lines was associated with its promoter methylation. Moreover, ectopic expression of ECRG4 markedly inhibited cell proliferation and invasion in renal cancer cell lines. These results indicated that ECRG4 is frequently silenced by the methylation of promoter in renal cell cancers. ECRG4 may be a tumor suppressor in renal cancer and serve as a prognostic marker.
KeywordsRenal cancer Prognosis ECRG4 Immunohistochemistry DNA methylation
This work was supported by grants from the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81201579), the National Key Scientific Program of China (Grant No. 2014CBA02005), and the National Natural Science Foundation of China (Grant No. 81272840, 81472584), Shenzhen Project of Science and Technology (Grant No. 20140416180149160, 201206133000192).
Conflicts of interest